Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles.
暂无分享,去创建一个
Diana Boraschi | Antonietta M Gatti | Paola Quattroni | E. Monari | D. Boraschi | A. Gatti | Marilena Lucarelli | Graziana Savarino | Lucia Martinelli | Emanuela Monari | P. Quattroni | M. Lucarelli | G. Savarino | L. Martinelli
[1] K. Driscoll,et al. Pulmonary response to inhaled silica or titanium dioxide. , 1991, Toxicology and applied pharmacology.
[2] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[3] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[4] K. Anderson,et al. Toll signaling pathways in the innate immune response. , 2000, Current opinion in immunology.
[5] C. Dinarello,et al. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.
[6] Larry L. Hench,et al. Biomaterials : an interfacial approach , 1982 .
[7] G. Valdrè,et al. Importance of microanalysis in understanding mechanism of transformation in active glassy biomaterials. , 1996, Journal of biomedical materials research.
[8] S. Goyert,et al. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. , 1997, Journal of immunology.
[9] L. O’Neill. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. , 2000, Biochemical Society transactions.
[10] M. Feldmann,et al. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.
[11] W. Arend. The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.
[12] David B Warheit,et al. TIME COURSE OF QUARTZ AND TiO 2 PARTICLE-INDUCED PULMONARY INFLAMMATION AND NEUTROPHIL APOPTOTIC RESPONSES IN RATS , 2002, Experimental lung research.
[13] Tomoki Ito,et al. Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance. , 2002, Human immunology.
[14] S. Swain,et al. Interleukin 18 , 2001, The Journal of experimental medicine.
[15] R. Weeratna,et al. The potential of CpG oligodeoxynucleotides as mucosal adjuvants. , 2001, Critical reviews in immunology.
[16] N Hussain,et al. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. , 2001, Advanced drug delivery reviews.
[17] B. Beutler,et al. TLR4 as the mammalian endotoxin sensor. , 2002, Current topics in microbiology and immunology.
[18] K. Xia,et al. Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. , 2003, Current gene therapy.
[19] G. Cooper,et al. Occupational exposure to crystalline silica and autoimmune disease. , 1999, Environmental health perspectives.
[20] D. Mosser,et al. The many faces of macrophage activation , 2003, Journal of leukocyte biology.
[21] F C Kafatos,et al. Phylogenetic perspectives in innate immunity. , 1999, Science.
[22] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[23] L. Babiuk,et al. Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits. , 2003, Vaccine.
[24] H. S. Warren,et al. Toll-like receptors. , 2005, Critical care medicine.
[25] A. Florence. Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting , 2004, Journal of drug targeting.
[26] R. Medzhitov,et al. Toll-like receptors and their ligands. , 2002, Current topics in microbiology and immunology.
[27] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[28] C. Janeway,et al. An ancient system of host defense. , 1998, Current opinion in immunology.
[29] Mitsunobu Sato,et al. Toll-like receptor signaling in anti-cancer immunity. , 2003, The journal of medical investigation : JMI.